JPRN-jRCTs051200021招募中2 期
Phase II study to evaluate the efficacy and safety of the introduction of high-dose chemotherapy comprising thiotepa and melphalan to conventional chemoradiotherapy depending on new risk classification for medulloblastoma - JCCG MB19
Hara Junichi0 个研究点目标入组 229 人开始时间: 2020年5月28日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 229
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 至 < 30age old（—）
- 性别
- All
入选标准
- •1) Locally diagnosed as medulloblastoma after tumor resection or biopsy
- •2) Protocol treatment can be started within 6 weeks after surgery
- •3) Less than 30 years
- •4) No prior radiation or chemotherapy
- •5) ECOG Performance Status (PS) is 3 or less
排除标准
- •1) Active double cancer (synchronous double cancer and metachronous double cancer with disease-free period of 5 years or less).
- •2) Complicated with extracranial metastasis (M4).
- •3) Complicated heart disease requiring treatment.
- •4) You are pregnant or nursing.
研究者
相似试验
招募中
2 期
Phase II study of multimodality treatment for ATRTAtypical teratoid rhabdoid tumorD016543JPRN-jRCTs051200071Junichi Hara50
尚未招募
2 期
Phase II study to evaluate the efficacy and safety of mirogabalin for CIPN in patients with gastrointestinal cancer.esophageal cancer, gastric cancer, small bowel cancer, colon cancer, pancreatic cancerJPRN-UMIN000049555ational Cancer Center Hospital30
招募中
2 期
Evaluation of the efficacy of bioadhesive barrier-forming oral liquid gel (Episil) for prevention of oral mucositisJPRN-jRCTs062220023Takano HIdeyuki50
尚未招募
2 期
Study to examine the efficacy and safety of Awa Suzuka extracted ingredientsHealthy subjects with serum triglyceride levels in the borderline rangeJPRN-UMIN000052759Tokushima University Graduate School40
招募中
2 期
Phase II study evaluating the efficacy and safety of the Bevacizumab / Docetaxel maintenance therapy beyond stable disease in patients with advanced relapsed non-squamous NSCLC who received Bevacizumab / pemetrexed / platinum induction therapyJPRN-UMIN000010055Respiratory Center, Showa University Northern Yokohama Hospital20